300119.SZ · 瑞普生物
China A-shares · RS rating 53 · As of 2026-10-14
| Price | 16.48 CNY |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 33 / 69 / 35 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 23 / 16 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +8.3% |
| Distance from 52-week high | +26.9% |
| Market cap (USD) | $1.2B |